caffeine has been researched along with MS (Multiple Sclerosis) in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association between alcohol and caffeine intakes and risk of multiple sclerosis (MS) is unclear; no prospective studies have examined this relationship." | 7.79 | Caffeine and alcohol intakes have no association with risk of multiple sclerosis. ( Ascherio, A; Massa, J; Munger, KL; O'Reilly, EJ, 2013) |
| "Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 5.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
| "The association between alcohol and caffeine intakes and risk of multiple sclerosis (MS) is unclear; no prospective studies have examined this relationship." | 3.79 | Caffeine and alcohol intakes have no association with risk of multiple sclerosis. ( Ascherio, A; Massa, J; Munger, KL; O'Reilly, EJ, 2013) |
| "Fluid intake and lower urinary tract symptoms were assessed by the questionnaire based voiding diary and the American Urological Association Symptom Score, respectively." | 1.56 | Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis. ( Cheung, A; Gross, MD; Kim, JM; Melville, PM; Tam, J; Weissbart, SJ, 2020) |
| "Caffeine treatment augmented A1AR expression on microglia, with ensuing reduction of EAE severity, which was further enhanced by concomitant treatment with the A1AR agonist, adenosine amine congener." | 1.32 | A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. ( Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, K | 1 |
| Fallon, SJ | 1 |
| Davis, T | 1 |
| Ankrett, S | 1 |
| Munro, G | 1 |
| Christopher, G | 1 |
| Coulthard, E | 1 |
| Herden, L | 1 |
| Weissert, R | 1 |
| Tam, J | 1 |
| Gross, MD | 1 |
| Cheung, A | 1 |
| Melville, PM | 1 |
| Kim, JM | 1 |
| Weissbart, SJ | 1 |
| Janitschke, D | 1 |
| Lauer, AA | 1 |
| Bachmann, CM | 1 |
| Grimm, HS | 1 |
| Hartmann, T | 1 |
| Grimm, MOW | 1 |
| Evans, E | 1 |
| Piccio, L | 1 |
| Cross, AH | 1 |
| Chen, GQ | 1 |
| Chen, YY | 1 |
| Wang, XS | 1 |
| Wu, SZ | 1 |
| Yang, HM | 1 |
| Xu, HQ | 1 |
| He, JC | 1 |
| Wang, XT | 1 |
| Chen, JF | 1 |
| Zheng, RY | 1 |
| Massa, J | 1 |
| O'Reilly, EJ | 1 |
| Munger, KL | 1 |
| Ascherio, A | 1 |
| FINKE, H | 1 |
| POPEK, K | 1 |
| Tsutsui, S | 1 |
| Schnermann, J | 1 |
| Noorbakhsh, F | 1 |
| Henry, S | 1 |
| Yong, VW | 1 |
| Winston, BW | 1 |
| Warren, K | 1 |
| Power, C | 1 |
| Maas, AG | 1 |
| Hogenhuis, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD:A Randomized, Double Blind, Placebo-controlled, Multicentric Trial.[NCT04284059] | Phase 4 | 504 participants (Anticipated) | Interventional | 2021-02-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for caffeine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Methylxanthines and Neurodegenerative Diseases: An Update.
Topics: Alzheimer Disease; Animals; Caffeine; Coffee; Humans; Multiple Sclerosis; Neurodegenerative Diseases | 2021 |
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
Topics: Acetylcarnitine; Animals; Ascorbic Acid; Biotin; Caffeine; Creatine; Curcumin; Dietary Supplements; | 2018 |
9 other studies available for caffeine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Preliminary evidence that caffeine improves attention in multiple sclerosis.
Topics: Attention; Attentional Blink; Caffeine; Cognition; Humans; Multiple Sclerosis; Reaction Time | 2022 |
The Effect of Coffee and Caffeine Consumption on Patients with Multiple Sclerosis-Related Fatigue.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Caffeine; Coffee; Disability Evaluation; Drinking Behavi | 2020 |
Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis.
Topics: Adult; Beverages; Caffeine; Cross-Sectional Studies; Drinking; Female; Humans; Lower Urinary Tract S | 2020 |
Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Topics: Animals; Caffeine; Central Nervous System; Cytokines; Disease Models, Animal; Dose-Response Relation | 2010 |
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Topics: Alcohol Drinking; Caffeine; Diet; Female; Humans; Multiple Sclerosis; Risk Factors; Surveys and Ques | 2013 |
[The treatment of spastic paralysis with intratendonous impletol injections].
Topics: Caffeine; Drug Combinations; Humans; Injections; Multiple Sclerosis; Muscle Spasticity; Paralysis; P | 1954 |
THE STUDY OF CHANGES IN THE SO-CALLED SUCCESSIVE CONTRAST IN NEUROLOGY.
Topics: Afterimage; Amphetamine; Arteriosclerosis; Brain Concussion; Brain Injuries; Brain Neoplasms; Bromid | 1964 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progre | 2004 |
Multiple sclerosis and possible relationship to cocoa: a hypothesis.
Topics: Animals; Cacao; Caffeine; England; Food Hypersensitivity; Humans; Israel; Multiple Sclerosis; Norway | 1987 |